10x Genomics, Inc. Share-based Payment Arrangement, Expense in USD from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
10x Genomics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to Q3 2025.
  • 10x Genomics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $25.3M, a 25.5% decline year-over-year.
  • 10x Genomics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $116M, a 21.5% decline year-over-year.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $141M, a 15.7% decline from 2023.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $167M, a 22% increase from 2022.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $137M, a 42.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

10x Genomics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $116M $25.3M -$8.65M -25.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 $124M $27.2M -$11.2M -29.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $136M $31.1M -$5.05M -14% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $141M $32.2M -$6.7M -17.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 $147M $33.9M -$6.33M -15.7% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 $154M $38.5M -$7.2M -15.8% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 $161M $36.1M -$5.97M -14.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 $167M $38.9M -$2.06M -5.02% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 $169M $40.2M +$6.72M +20.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $162M $45.7M +$9.38M +25.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $153M $42.1M +$16.1M +61.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $137M $41M +$14.1M +52.3% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 $123M $33.5M +$7.56M +29.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $115M $36.3M +$9.38M +34.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $106M $26M +$9.87M +61% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $96M $26.9M +$12.6M +88.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $83.3M $26M +$12.2M +88.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $71.2M $26.9M +$13.1M +94.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $58.1M $16.2M +$9.46M +141% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $48.6M $14.3M +$9.19M +181% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $39.4M $13.8M +$9.91M +256% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $29.5M $13.9M +$10.8M +358% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $18.7M $6.72M +$5.36M +394% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $13.3M $5.08M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $3.87M +$3.29M +558% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $3.03M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.36M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 $589K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12

10x Genomics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $141M -$26.2M -15.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $167M +$30.1M +22% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $137M +$40.9M +42.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $96M +$47.3M +97.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $48.6M +$35.3M +265% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $13.3M +$10.7M +402% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $2.66M +$997K +60% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $1.66M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.